In a pathological condition, such as postmenopausal osteoporosis, reduced estrogen levels cause decreased OPG, and consequently, increased RANKL, leading to increased osteoclastic bone resorption and bone loss [125]. This evidence concerns the gene TNFSF11 and postmenopausal osteoporosis.